We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AER icon
1126
AerCap
AER
$23.5B
– –
-3,032
Closed -$355K
AGX icon
1127
Argan
AGX
$8.15B
– –
-1,455
Closed -$321K
AGS
1128
DELISTED
PlayAGS
AGS
– –
-316,906
Closed -$3.96M
AIT icon
1129
Applied Industrial Technologies
AIT
$13.2B
– –
-2,208
Closed -$513K
ALC icon
1130
Alcon
ALC
$35.9B
– –
-14,589
Closed -$1.29M
ALGT icon
1131
Allegiant Air
ALGT
$2.41B
– –
-4,743
Closed -$261K
AMBA icon
1132
Ambarella
AMBA
$3.6B
– –
-3,692
Closed -$244K
AMED
1133
DELISTED
Amedisys
AMED
– –
-90,361
Closed -$8.89M
ANSS
1134
DELISTED
Ansys
ANSS
– –
-5,216
Closed -$1.83M
APA icon
1135
APA Corp
APA
$14.4B
– –
-18,964
Closed -$347K
APLS
1136
DELISTED
Apellis Pharmaceuticals
APLS
– –
-31,139
Closed -$539K
APTV icon
1137
Aptiv
APTV
$10.3B
– –
-3,043
Closed -$208K
ARCT icon
1138
Arcturus Therapeutics
ARCT
$200M
– –
-23,160
Closed -$301K
ARE icon
1139
Alexandria Real Estate Equities
ARE
$8.32B
– –
-4,630
Closed -$336K
ARQT icon
1140
Arcutis Biotherapeutics
ARQT
$3.26B
– –
-15,203
Closed -$213K
ARVN icon
1141
Arvinas
ARVN
$588M
– –
-11,045
Closed -$81.3K
ASTE icon
1142
Astec Industries
ASTE
$991M
– –
-8,809
Closed -$367K
ASTS icon
1143
AST SpaceMobile
ASTS
$20.5B
– –
-8,523
Closed -$398K
AZEK
1144
DELISTED
The AZEK Co
AZEK
– –
-50,983
Closed -$2.77M
AZO icon
1145
AutoZone
AZO
$50.1B
– –
-58
Closed -$215K
BASE
1146
DELISTED
Couchbase
BASE
– –
-177,662
Closed -$4.33M
BBD icon
1147
Banco Bradesco
BBD
$36.3B
– –
-102,000
Closed -$315K
BCRX icon
1148
BioCryst Pharmaceuticals
BCRX
$2.51B
– –
-60,897
Closed -$546K
BDX icon
1149
Becton Dickinson
BDX
$48.9B
– –
-1,409
Closed -$243K
BHP icon
1150
BHP
BHP
$230B
– –
-43,061
Closed -$2.07M
44 45
46
47 48

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.